Overview:

A Complete Blood Count (CBC) is a standard hematological analysis that yields crucial data regarding the cellular components of your blood. It quantifies and characterizes erythrocytes, leukocytes, and thrombocytes. The CBC is instrumental for healthcare professionals in assessing overall health and identifying conditions such as anemia, infectious processes, inflammatory responses, and specific hematological disorders.

The Fasting Blood Sugar (FBS) test, also referred to as Fasting Plasma Glucose, is primarily employed for the screening of diabetes and prediabetes. This test quantifies the glucose concentration in your blood following an overnight fasting period of at least 8 hours. Fasting is essential to ensure a precise baseline measurement uninfluenced by recent dietary intake.

A Lipid Profile test assesses the concentrations of various lipids in the blood to evaluate the risk of cardiovascular diseases, including myocardial infarction and cerebrovascular accidents. This test can be conducted in either a fasting state (8 to 12 hours without food or beverages, excluding water) or a non-fasting state, contingent upon a physician's recommendation. Fasting is generally preferred for accurate triglyceride measurements.

Kidney Function Test (KFT): The Serum Creatinine test is a routine blood analysis that gauges the efficiency of renal filtration of metabolic waste products from the bloodstream. Urea is another waste product formed in the liver from the breakdown of proteins and is excreted by the kidneys. BUN is a measure of the nitrogen part of urea in the blood.

A Serum Electrolyte test measures the concentrations of vital minerals in the blood that govern essential physiological processes, including fluid homeostasis, muscular contraction, and neural transmission.

A Urine Routine Examination (Urine R/E) involves the analysis of the physical, chemical, and microscopic attributes of urine to ascertain renal health, detect infections, and evaluate metabolic or systemic conditions.

Liver Function Test (LFT) is a blood test panel that evaluates liver health and function by measuring enzymes, proteins, and bilirubin levels. It helps detect or monitor liver injury, inflammation, bile flow problems, and conditions such as hepatitis or fatty liver disease. Abnormal results may require further evaluation based on symptoms and medical history.

TSH (Thyroid Stimulating Hormone): Produced by the pituitary gland, TSH stimulates the thyroid gland to produce T4 hormone. A high TSH level indicates hypothyroidism (underactive thyroid), while low TSH indicates hyperthyroidism (overactive thyroid).

FT4 (Free Thyroxine): FT4 levels can help indicate thyroid function and diagnose disorders like hypothyroidism or hyperthyroidism.

Risk Assessment:

This screening panel is designed to help identify potential risk factors and early indicators of various common health conditions. These include:

Anemia, infections, and blood disorders: These are assessed through a Complete Blood Count (CBC).
Cardiovascular disease risk: This is evaluated using a Lipid Profile.
Kidney dysfunction: This is assessed through Serum Creatinine and a Urine Routine Examination.
Liver abnormalities: These are evaluated using ALT (SGPT).
Diabetes and impaired glucose regulation: These are screened through Random Blood Sugar (RBS) and a Urine Routine Examination.

Normal Ranges:

Interpretation :

Sample Type:

1. Serum or plasma from venous blood. Usually requires fasting (8 to 12 hours) for accurate result.
2. Fresh midstream urine sample. Collection method: Clean-catch, midstream technique is recommended to avoid contamination.